Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
Tabla de Políticas Médicas
| ID | Título | Revisión | Descripción | Acceso |
|---|---|---|---|---|
| 03.001.009 | Digital Health Therapies For Substance Abuse | Aug 2024 | The world health organization defines substance use disorder as “the harmful or hazardous use of... | Ver |
| 03.001.010 | Digital Health Therapies For Attention Deficit/Hyperactivity Disorder | Aug 2026 | Digital health technologies is a broad term that includes categories such as mobile health, health... | Ver |
| 03.003.001 | Therapeutic Radiopharmaceuticals for Prostate Cancer | Nov 2025 | ... | Ver |
| 04.001.001 | Evaluación fetal anteparto | Jun 2022 | In humans as well as in animals, the fetal heart rate pattern, activity level, and degree of fetal muscle... | Ver |
| 04.001.003 | Home Uterine Activity Monitoring | May 2019 | The home uterine activity monitor (huam) is a device that can be worn by pregnant women and is intended to... | Ver |
| 04.001.007 | Occlusion Of Uterine Arteries Using Transcatheter Embolization | Sep 2020 | ... | Ver |
| 04.001.009 | Laparoscopic And Percutaneous Techniques For The Myolysis Of Uterine Fibroids | Mar 2026 | Various minimally invasive treatments for uterine fibroids have been proposed as alternatives to surgery.... | Ver |
| 04.001.010 | Oclusión histeroscópica de los tubos de falopio como método contraceptivo | May 2016 | ... | Ver |
| 04.001.011 | Ovarian And Internal Iliac Vein Endovascular Occlusion As A Treatment Of Pelvic Congestion Syndrome | Sep 2026 | Pelvic congestion syndrome is characterized by chronic pelvic pain that is often aggravated by standing;... | Ver |
| 04.001.012 | Progesterone Therapy As A Technique To Reduce Preterm Delivery In High-Risk Pregnancies | Oct 2024 | Preterm birth is the leading cause of neonatal morbidity and mortality, and effective primary preventive... | Ver |
| 04.001.013 | Ablación del Endometrio | Aug 2017 | ... | Ver |
| 04.001.019 | Robotic Surgery In Gynecology | Oct 2023 | In the decade of the ‘80s, the idea of having a military ambulance in the battlefield; equipped with a... | Ver |
| 04.001.020 | Obstetric Ultrasonography | Sep 2024 | Obstetric ultrasonography is an ultrasound examination with an instrument in real time, using transabdominal... | Ver |
| 04.001.024 | Services For Intra-Uterine Device Management | Nov 2022 | The intrauterine device (iud) is the most commonly used method of long-acting reversible contraception... | Ver |
| 04.002.002 | Cirugía fetal para malformaciones congénitas diagnosticadas en periodo perinatal | Dec 2022 | Fetal surgery is used for specific congenital abnormalities associated with a poor postnatal prognosis.... | Ver |
| 04.002.004 | GENDER AFFIRMING SURGERY | Aug 2026 | This policy addresses gender affirming surgery (also known as sex affirmation surgery, gender or sex... | Ver |
| 04.002.005 | Reproductive Techniques | Sep 2026 | A variety of techniques are available to establish a viable pregnancy for couples who have been diagnosed... | Ver |
| 05.001.004 | Botulinum Toxin | Nov 2025 | Botulinum is a family of toxins produced by the anaerobic organism clostridia botulinum. multiple... | Ver |
| 05.001.005 | Human Growth Hormone | Nov 2025 | Recombinant human growth hormone (gh) is approved by the u.s. food and drug administration (fda) for various... | Ver |
| 05.001.006 | Recombinant And Autologous Platelet-Derived Growth Factors For Wound Healing And Other Non‒Orthopedic Conditions | Feb 2026 | The use of blood-derived growth factors, including recombinant platelet-derived growth factors (pdgfs) and... | Ver |